Targeting PPT1 with ezurpimtrostat sensitives liver tumor to immunotherapy by switching cold into hot microenvironments https://www.biorxiv.org/content/10.1101/2023.01.18.524541v1?med=mas
Targeting PPT1 with ezurpimtrostat sensitives liver tumor to immunotherapy by switching cold into hot microenvironments https://www.biorxiv.org/content/10.1101/2023.01.18.524541v1?med=mas